123 related articles for article (PubMed ID: 9234348)
1. Metabolism of a [18F]fluorine labeled progestin (21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone) in humans: a clue for future investigations.
Verhagen A; Studeny M; Luurtsema G; Visser GM; De Goeij CC; Sluyser M; Nieweg OE; Van der Ploeg E; Go KG; Vaalburg W
Nucl Med Biol; 1994 Oct; 21(7):941-52. PubMed ID: 9234348
[TBL] [Abstract][Full Text] [Related]
2. A fluorine-18 labeled progestin as an imaging agent for progestin receptor positive tumors with positron emission tomography.
Verhagen A; Elsinga PH; de Groot TJ; Paans AM; de Goeij CJ; Sluyser M; Vaalburg W
Cancer Res; 1991 Apr; 51(7):1930-3. PubMed ID: 2004378
[TBL] [Abstract][Full Text] [Related]
3. Assessment of 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas.
Dehdashti F; McGuire AH; Van Brocklin HF; Siegel BA; Andriole DP; Griffeth LK; Pomper MG; Katzenellenbogen JA; Welch MJ
J Nucl Med; 1991 Aug; 32(8):1532-7. PubMed ID: 1869974
[TBL] [Abstract][Full Text] [Related]
4. 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone: synthesis and target tissue selective uptake of a progestin receptor based radiotracer for positron emission tomography.
Pomper MG; Katzenellenbogen JA; Welch MJ; Brodack JW; Mathias CJ
J Med Chem; 1988 Jul; 31(7):1360-3. PubMed ID: 3260285
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of a positron emitting progestin ([18F]fluoro-16 alpha-methyl-19-norprogesterone) for imaging progesterone receptor positive tumours with positron emission tomography.
Verhagen A; Luurtsema G; Pesser JW; de Groot TJ; Wouda S; Oosterhuis JW; Vaalburg W
Cancer Lett; 1991 Aug; 59(2):125-32. PubMed ID: 1884369
[TBL] [Abstract][Full Text] [Related]
6. PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.
Jonson SD; Welch MJ
Q J Nucl Med; 1998 Mar; 42(1):8-17. PubMed ID: 9646640
[TBL] [Abstract][Full Text] [Related]
7. 16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors.
VanBrocklin HF; Carlson KE; Katzenellenbogen JA; Welch MJ
J Med Chem; 1993 May; 36(11):1619-29. PubMed ID: 7684451
[TBL] [Abstract][Full Text] [Related]
8. Fluorine-18-labeled progestin 16 alpha, 17 alpha-dioxolanes: development of high-affinity ligands for the progesterone receptor with high in vivo target site selectivity.
Buckman BO; Bonasera TA; Kirschbaum KS; Welch MJ; Katzenellenbogen JA
J Med Chem; 1995 Jan; 38(2):328-37. PubMed ID: 7830275
[TBL] [Abstract][Full Text] [Related]
9. The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer.
Katzenellenbogen JA; Welch MJ; Dehdashti F
Anticancer Res; 1997; 17(3B):1573-6. PubMed ID: 9179196
[TBL] [Abstract][Full Text] [Related]
10. Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography.
Lee JH; Zhou HB; Dence CS; Carlson KE; Welch MJ; Katzenellenbogen JA
Bioconjug Chem; 2010 Jun; 21(6):1096-104. PubMed ID: 20496889
[TBL] [Abstract][Full Text] [Related]
11. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
Mortimer JE; Dehdashti F; Siegel BA; Katzenellenbogen JA; Fracasso P; Welch MJ
Clin Cancer Res; 1996 Jun; 2(6):933-9. PubMed ID: 9816253
[TBL] [Abstract][Full Text] [Related]
13. Estrogen- and progesterone-receptors in meningiomas. Review article.
Goffin J
Clin Neurol Neurosurg; 1986; 88(3):169-75. PubMed ID: 3536253
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies.
Zhou D; Sharp TL; Fettig NM; Lee H; Lewis JS; Katzenellenbogen JA; Welch MJ
Nucl Med Biol; 2008 Aug; 35(6):655-63. PubMed ID: 18678350
[TBL] [Abstract][Full Text] [Related]
15. Steroid receptor status difference in recurrent intracranial meningioma and breast cancer in the same patient.
Magdelenat H; Pertuiset BF; Poisson M; Philippon J
J Neurooncol; 1986; 4(2):155-7. PubMed ID: 3023558
[TBL] [Abstract][Full Text] [Related]
16. Metabolic fates of 2'-deoxy-5-[18F]fluorouridine in tumor-bearing mice and human plasma.
Ishiwata K; Sato K; Kameyama M; Yoshimoto T; Ido T
Int J Rad Appl Instrum B; 1991; 18(5):539-45. PubMed ID: 1833361
[TBL] [Abstract][Full Text] [Related]
17. Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors.
Wiebe JP; Zhang G; Welch I; Cadieux-Pitre HA
Breast Cancer Res; 2013 May; 15(3):R38. PubMed ID: 25927181
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen receptors in meningiomas: a correlative PET and immunohistochemical study.
Moresco RM; Scheithauer BW; Lucignani G; Lombardi D; Rocca A; Losa M; Casati R; Giovanelli M; Fazio F
Nucl Med Commun; 1997 Jul; 18(7):606-15. PubMed ID: 9342097
[TBL] [Abstract][Full Text] [Related]
19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer models to study the expression of estrogen receptors with small animal PET imaging.
Aliaga A; Rousseau JA; Ouellette R; Cadorette J; van Lier JE; Lecomte R; Bénard F
Nucl Med Biol; 2004 Aug; 31(6):761-70. PubMed ID: 15246367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
